DcR3/TNFRSF6B ELISA DY142 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemDcR3/TNFRSF6B ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $890.00Supplier Page View Company Product Page
Catalog NumberDY142
Quantity1 Kit (for 15 Plates)
ApplicationsELISA
Detection Range187.00 - 12000 pg/mL
ReactivityHuman
Detection TargetDcR3/TNFRSF6B
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameTNF receptor superfamily member 6b
NCBI Gene AliasesDCR3, DJ583P15.1.1, M68, M68E, TR6

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 15 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) DcR3 Suppresses Lipopolysaccharide-Induced Aggresome-like Structures in Macrophages via Inhibition of Reactive Oxygen Species and p38 MAPKInt J Mol SciJuly 20, 2026Chun-Hung Lee, Duen-Yi Huang, Shie-Liang Hsieh, Yuan-Shen Chen, Wan-Wan LinCollege of Public Health. 4.3. Enzyme-Linked Immunosorbent Assay (ELISA) of DcR3 DuoSet ELISA kit (DY142, R&D Systems, Minneapolis, MN, USA) was used for the determination of DcR3 level in mouse serum following

(2) Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activationExperimental & molecular medicineApril 1, 2022Wu NL, Huang DY, Hsieh SL, Dai YS, Lin WW.

(3) Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathwayCellular signallingOctober 1, 2019Liang DY, Sha S, Yi Q, Shi J, Chen Y, Hou Y, Chang Q.

(4) DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathwayOncoTargets and therapyJanuary 1, 2018Ge H, Liang C, Li Z, An D, Ren S, Yue C, Wu J.

(5) Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosisOncoTargets and therapyJanuary 1, 2017Liang C, Xu Y, Li G, Zhao T, Xia F, Li G, Zhang D, Wu J.

(6) Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis populationScientific reportsOctober 5, 2016Shu CC, Hsu CL, Lee CY, Wu VC, Yang FJ, Wang JY, Yu CJ, Lee LN.

(7) Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver DiseaseCanadian journal of gastroenterology & hepatologyJanuary 1, 2016Bamias G, Gizis M, Delladetsima I, Laoudi E, Siakavellas SI, Koutsounas I, Kaltsa G, Vlachogiannakos J, Vafiadis-Zouboulis I, Daikos GL, et al.

(8) Chronic lymphocytic leukemia: a paradigm of innate immune cross-toleranceJournal of immunology (Baltimore, Md. : 1950)January 15, 2015Jurado-Camino T, Córdoba R, Esteban-Burgos L, Hernández-Jiménez E, Toledano V, Hernandez-Rivas JA, Ruiz-Sainz E, Cobo T, Siliceo M, Perez de Diego R, et al.

(9) Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis predictionBMC infectious diseasesJanuary 28, 2013Shu CC, Wu MF, Hsu CL, Huang CT, Wang JY, Hsieh SL, Yu CJ, Lee LN, Yang PC.

(10) DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1BMC cancerMay 14, 2012Connor JP, Felder M, Kapur A, Onujiogu N.

(11) Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndromeAmerican journal of respiratory and critical care medicineOctober 15, 2009Chen CY, Yang KY, Chen MY, Chen HY, Lin MT, Lee YC, Perng RP, Hsieh SL, Yang PC, Chou TY.

(12) Response to Comment on â€œDecoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-ÎºB-Dependent Pathwayâ€The Journal of ImmunologyAugust 15, 2009Chia-Ron Yangof DcR3 concentration between us. We used a commercial DuoSet ELISA development system (catalog number DY142; R&D Systems) to detect DcR3 expression levels, and all of our results were comprehended within the

(13) "Comment on ""Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway"""Journal of immunology (Baltimore, Md. : 1950)August 15, 2009Wang W, Sun W, Zhang L.of DcR3 concentration between us. We used a commercial DuoSet ELISA development system (catalog number DY142; R&D Systems) to detect DcR3 expression levels, and all of our results were comprehended within the

(14) The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluidJournal of neuroimmunologyApril 30, 2009Mueller AM, Pedré X, Killian S, David M, Steinbrecher A.

(15) Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathwayJournal of immunology (Baltimore, Md. : 1950)December 15, 2008Chen PH, Yang CR.

(16) Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3BloodMay 15, 2008Chang YC, Chen TC, Lee CT, Yang CY, Wang HW, Wang CC, Hsieh SL.

Be the First to Write a Review!

DcR3/TNFRSF6B ELISA

Human DcR3/TNFRSF6B DuoSet ELISA

DcR3/TNFRSF6B ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (16)

Reviews

DcR3/TNFRSF6B ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map